Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Author Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Author Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Abstract

Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: findings of the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT).

Christian E Antoni, Arthur Kavanaugh, Désirée van der Heijde, Anna Beutler, Gregory Keenan, Bei Zhou, Bruce Kirkham, Zuhre Tutuncu, Gerd R Burmester, Udo Schneider, Daniel E Furst, Jerry Molitor, Edward Keystone, Dafna D Gladman, Bernhard Manger, Siegfried Wassenberg, Ralf Weier, Daniel J Wallace, Michael H Weisman, Joachim R Kalden and Josef S Smolen
The Journal of Rheumatology May 2008, 35 (5) 869-876;
Christian E Antoni
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arthur Kavanaugh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Désirée van der Heijde
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Beutler
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gregory Keenan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bei Zhou
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruce Kirkham
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zuhre Tutuncu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerd R Burmester
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Udo Schneider
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel E Furst
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jerry Molitor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edward Keystone
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dafna D Gladman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bernhard Manger
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Siegfried Wassenberg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ralf Weier
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel J Wallace
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael H Weisman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joachim R Kalden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Josef S Smolen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • References
  • Info & Metrics
  • PDF
  • eLetters
PreviousNext
Loading

Article Information

vol. 35 no. 5 869-876
PubMed 
18381786

Published By 
The Journal of Rheumatology
Print ISSN 
0315-162X
Online ISSN 
1499-2752
History 
  • Published online May 1, 2008.


Author Information

  1. Christian E Antoni,
  2. Arthur Kavanaugh,
  3. Désirée van der Heijde,
  4. Anna Beutler,
  5. Gregory Keenan,
  6. Bei Zhou,
  7. Bruce Kirkham,
  8. Zuhre Tutuncu,
  9. Gerd R Burmester,
  10. Udo Schneider,
  11. Daniel E Furst,
  12. Jerry Molitor,
  13. Edward Keystone,
  14. Dafna D Gladman,
  15. Bernhard Manger,
  16. Siegfried Wassenberg,
  17. Ralf Weier,
  18. Daniel J Wallace,
  19. Michael H Weisman,
  20. Joachim R Kalden, and
  21. Josef S Smolen
  1. Clinical Immunology, Schering-Plough Corporation, Kenilworth, New Jersey 07033-0530, USA. christian.antoni@spcorp.com

Article usage

Article usage: January 2009 to April 2022

AbstractFullPdf
Jan 200952013
Feb 200960010
Mar 200958020
Apr 200954037
May 200933022
Jun 200956029
Jul 200932026
Aug 200927018
Sep 200935031
Oct 200946051
Nov 200944040
Dec 200933027
Jan 201057038
Feb 201034022
Mar 201056029
Apr 201036024
May 201017028
Jun 201020020
Jul 201026024
Aug 201061025
Sep 201040031
Oct 201029029
Nov 201033014
Dec 201026024
Jan 201139018
Feb 201124021
Mar 201130032
Apr 201119024
May 201129013
Jun 201122014
Jul 201130016
Aug 201146019
Sep 20112807
Oct 201135015
Nov 201133017
Dec 20112406
Jan 201228017
Feb 201222018
Mar 201225022
Apr 201233014
May 201233013
Jun 20121808
Jul 201220016
Aug 20124509
Sep 20121608
Oct 201219023
Nov 20122109
Dec 20121607
Jan 20139127
Feb 201327011
Mar 20133007
Apr 201332015
May 20132204
Jun 201334010
Jul 2013909
Aug 201317022
Sep 201315012
Oct 201314025
Nov 20131807
Dec 201323012
Jan 20142009
Feb 201418020
Mar 201416015
Apr 20141105
May 201415011
Jun 20149013
Jul 201416015
Aug 201420022
Sep 201428012
Oct 20144708
Nov 20149113
Dec 20144016
Jan 201520015
Feb 201531020
Mar 201535015
Apr 2015906
May 20151508
Jun 20152907
Jul 201512010
Aug 20152707
Sep 201545014
Oct 201518024
Nov 201510010
Dec 201526011
Jan 20162309
Feb 20166706
Mar 201616010
Apr 20161904
May 20162809
Jun 20162108
Jul 20165503
Aug 201653012
Sep 201644011
Oct 20164705
Nov 20166409
Dec 20167407
Jan 20178005
Feb 20177909
Mar 20177506
Apr 20175704
May 20179308
Jun 201796013
Jul 201798011
Aug 201767010
Sep 20179206
Oct 201770022
Nov 2017106014
Dec 20177308
Jan 201869010
Feb 20184803
Mar 201810405
Apr 20187709
May 20186605
Jun 20187304
Jul 201811709
Aug 20187803
Sep 20187703
Oct 2018104011
Nov 2018135014
Dec 20187206
Jan 20197600
Feb 20194403
Mar 20196006
Apr 201910006
May 201958010
Jun 201967015
Jul 20192402
Aug 20193605
Sep 20194802
Oct 20194702
Nov 20195406
Dec 20198602
Jan 202055013
Feb 202034023
Mar 202015011
Apr 202024020
May 202019017
Jun 202014017
Jul 2020907
Aug 20206010
Sep 202024014
Oct 202023010
Nov 202052015
Dec 202024018
Jan 202130014
Feb 202129011
Mar 202143013
Apr 202130018
May 202173019
Jun 20212206
Jul 2021805
Aug 202134031
Sep 202131016
Oct 202132017
Nov 202140019
Dec 20211906
Jan 20221107
Feb 202232011
Mar 202234015
Apr 202219010

Statistics from Altmetric.com

PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 35, Issue 5
1 May 2008
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: findings of the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT).
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: findings of the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT).
Christian E Antoni, Arthur Kavanaugh, Désirée van der Heijde, Anna Beutler, Gregory Keenan, Bei Zhou, Bruce Kirkham, Zuhre Tutuncu, Gerd R Burmester, Udo Schneider, Daniel E Furst, Jerry Molitor, Edward Keystone, Dafna D Gladman, Bernhard Manger, Siegfried Wassenberg, Ralf Weier, Daniel J Wallace, Michael H Weisman, Joachim R Kalden, Josef S Smolen
The Journal of Rheumatology May 2008, 35 (5) 869-876;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: findings of the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT).
Christian E Antoni, Arthur Kavanaugh, Désirée van der Heijde, Anna Beutler, Gregory Keenan, Bei Zhou, Bruce Kirkham, Zuhre Tutuncu, Gerd R Burmester, Udo Schneider, Daniel E Furst, Jerry Molitor, Edward Keystone, Dafna D Gladman, Bernhard Manger, Siegfried Wassenberg, Ralf Weier, Daniel J Wallace, Michael H Weisman, Joachim R Kalden, Josef S Smolen
The Journal of Rheumatology May 2008, 35 (5) 869-876;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • References
  • Info & Metrics
  • PDF
  • eLetters

Related Articles

Cited By...

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire